https://www.selleckchem.com/pr....oducts/tefinostat.ht
05) increase in the cell viability in a dose-dependent manner of inhibin A. Likewise, MMP was significantly (p less then 0.05) enhanced when GCs were treated with high doses (50, 100 ng/mL) of inhibin A. Furthermore, inhibin A dose (100 ng/mL) markedly improved the progression of the G1 phase of the cell cycle and increased the cell number in the S phase, which was supported by the up-regulation of the proliferating cell nuclear antigen PCNA (20, 50, and 100ng/mL) and CyclinB (100 ng/mL) genes. In addition, higher doses of inhibin A
Like
Comment
Share
